Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity
摘要
Outcomes following international MDT assessment of adult IEI patients for allogeneic HSCT suggest early referral is vital: patients considered too high risk for transplant have poor outcomes with a 3-year overall survival of 31%.